3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Breast Neoplasms
13
Colorectal Neoplasms
6
Neoplasms
4
Thyroid Neoplasms
3
Prostatic Neoplasms
3
Ovarian Neoplasms
2
Colonic Neoplasms
2
Uterine Cervical Neoplasms
1
Unmet Fertility Information Needs
1
Thyroid Cancer, Papillary
1
Smoking Cessation
1
Patient Participation
1
Papillary Thyroid Microcarcinoma
1
Neuroma, Acoustic
1
Melanoma
1
Lymphoma, Follicular
1
Lung Neoplasms
1
Kidney Neoplasms
1
Healthy Volunteers
1
Depression
1
Dementia
1
Colorectal Cancer Screening
1
Carcinoma, Renal Cell
1
Carcinoma, Medullary
1
Carcinoma, Intraductal, Noninfiltrating
1
COVID-19
1
Breast Carcinoma In Situ
1
Behavior
1
Advanced Cancer
1
Interventions
liposomal doxorubicin
1
Widowhood
1
Videotape Recording
1
TKN732
1
Surveys and Questionnaires
1
Saline Solution
1
Melphalan
1
Leucine-tRNA Ligase
1
Decision Support Techniques
1
Control Groups
1
Capecitabine
1
Bortezomib
1
Blood Transfusion
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Patient Participation
×
Decision Support Techniques
×
Clear all
NCT04240717
2022-11-07
PEF-Immun
University Hospital Heidelberg
Phase NA
Completed
126 enrolled